News

As part of the agreement, Chiesi will distribute the product in Europe, Turkey and former CIS countries including promoting the drug, identifying patients and handling reimbursements. Kamada will

The product has been developed by Schoeller-Bleckmann Medizintechnik (SBM), a subsidiary of Bosch Packaging Technology. SBM general manager Alfred Kaliwoda said the systems achieve an availability of up

The assay will offer stand-alone test in conjunction with a new comprehensive prognostic profiling panel for patients with chronic lymphocytic leukemia (CLL). The CLL Profile panel also includes

A candidate vaccine consisting of the antigens reduced viral shedding and clinical disease when tested in a preclinical model of HSV-2 infection. Herpes simplex virus type 2 (HSV-2)

According to the non-exclusive license agreement, Marina will receive $1m upfront payment. Marina Biotech president and chief executive officer Michael French said Marina’s CRN is quite versatile and

The approval of the manufacturing facility allows Isis to supply Genzyme with Kynamro drug substance to support its commercial launch in Europe. Isis chief operating officer, chief financial

As a part of the agreement, XOMA’s technology and process for the commercial manufacture of gevokizumab, XOMA’s novel interleukin 1-beta allosteric modulating antibody will be transferred to Boehringer.

Under the license, Paragon will use Cevec’s CAP and CAP-T cell expression system to perform process development and develop stable cell lines for the contract manufacturing of recombinant

The study evaluating the efficacy and safety of Toviaz 8mg (fesoterodine fumarate) in patients with overactive bladder (OAB), who had been taking Detrol LA 4mg for two weeks,